ArticleHealth science reports2025
Finding the Context of High-Risk Behavioral Factors and the Effectiveness of Addiction Treatment Centers in Preventing the Transmission of Hepatitis C Virus Among Injecting Drug Addicts: "Southeastern Iran".
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hepatitis C virus (HCV) infection is a major global health issue. Injecting drug users (IDUs) are an important group at risk of HCV infection. Therefore, this study was undertaken to determine the related high-risk behavioral factors and the effectiveness of addiction treatment centers in preventing the transmission of HCV among IDUs referring to governmental methadone maintenance treatment (MMT) centers in Southeast Iran. Methods: This analytical study was conducted as a pre- and post-intervention assessment without a control group in first 6 months of 2022. 313 IDUs receiving methadone from five governmental MMT centers in Kerman were interviewed in the form of a census. Effectiveness was measured using mathematical formulas and patterns based on high-risk injecting behaviors. Results: Of the 313 participants, 299 (95.84%) were men, the mean age ± SD was 41.06 ± 8.73 years and HCV prevalence was 113 (36.1%). The results showed that MMT centers avoided 23.55 new cases of HCV per 100 people. The studied IDUs reported minor rate of risky injecting and sexual behavior after participation in MMT program. The communal incidence of HCV per 100 IDUs due to shared injection and unsafe sexual connection with MMT program were 13.89 (95% CI: 5.43-19.63), 0.0003 (0.0002-0.0007) and without it 37.44 (24.34-46.78) and 0.0002 (0.0001-0.0004) respectively. Conclusion: The MMT program is an effective intervention to prevent HCV infection, a comparison of its effectiveness with other interventions is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.